Acadia Healthcare Company, Inc. (ACHC) Presents at Leerink Global Healthcare Conference 2026 Transcript

Benjamin Mayo
Leerink Partners LLC, Research Division

I thought it would be maybe helpful to start since Todd is relatively new to the organization joining in a time of change and you’ve been at other places in your career. I wanted to hear kind of observations around some of the strengths and weaknesses that you’ve identified within either the company operations, the finance functions. And maybe we’ll just start there.

Todd Young
Chief Financial Officer

Sure. Yes. I joined Acadia 4 months ago, right at the end of October. So still new, getting used to being on the services side of health care grew up on the product side, including at Acadia Pharma, which has created a little confusion as I joined Acadia Healthcare.

Overall, the company is in a really good spot from a market positioning standpoint. The demand for our services continue to grow, and we’ve got a nice diversified business across both the acute inpatient, specialty inpatient, residential as well as the outpatient business with our opioid replacement therapy, what we call CTC. So I think all of those give us a really good spot to drive growth from.

Overall, I mean, the organization is very pleased that Debbie Osteen is back as CEO. Debbie joined us back in mid-January. And so her history in the industry and her proven track record of operating facilities is really something that’s breathed fresh life into the employee base and